Palisade Bio (PALI)

• Market cap: $302M
• 1 day: -9.55%
• 5 days: -10%
• 1 month: -3.74%
• 3 months: 4.65%
• 6 months: 1.69%
• Year to date: -28%
• 1 year: 135.32%
• 5 years: -99.96%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Employees: 14